Add like
Add dislike
Add to saved papers

Numerical and Clinical Evaluation of the Robustness of Open-source Networks for Parallel MR Imaging Reconstruction.

PURPOSE: Deep neural networks (DNNs) for MRI reconstruction often require large datasets for training. Still, in clinical settings, the domains of datasets are diverse, and how robust DNNs are to domain differences between training and testing datasets has been an open question. Here, we numerically and clinically evaluate the generalization of the reconstruction networks across various domains under clinically practical conditions and provide practical guidance on what points to consider when selecting models for clinical application.

METHODS: We compare the reconstruction performance between four network models: U-Net, the deep cascade of convolutional neural networks (DC-CNNs), Hybrid Cascade, and variational network (VarNet). We used the public multicoil dataset fastMRI for training and testing and performed a single-domain test, where the domains of the dataset used for training and testing were the same, and cross-domain tests, where the source and target domains were different. We conducted a single-domain test (Experiment 1) and cross-domain tests (Experiments 2-4), focusing on six factors (the number of images, sampling pattern, acceleration factor, noise level, contrast, and anatomical structure) both numerically and clinically.

RESULTS: U-Net had lower performance than the three model-based networks and was less robust to domain shifts between training and testing datasets. VarNet had the highest performance and robustness among the three model-based networks, followed by Hybrid Cascade and DC-CNN. Especially, VarNet showed high performance even with a limited number of training images (200 images/10 cases). U-Net was more robust to domain shifts concerning noise level than the other model-based networks. Hybrid Cascade showed slightly better performance and robustness than DC-CNN, except for robustness to noise-level domain shifts. The results of the clinical evaluations generally agreed with the results of the quantitative metrics.

CONCLUSION: In this study, we numerically and clinically evaluated the robustness of the publicly available networks using the multicoil data. Therefore, this study provided practical guidance for clinical applications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app